ZONISAMIDE-13C2-15N

ZONISAMIDE-13C2-15N Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:Zonisamide-13C2,15N
CAS:1188265-58-8
Package:1mg;990USD
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532; 18210857532
Email: jkinfo@jkchemical.com
Products Intro: Product Name:ZonisaMide-13C2-15N
CAS:1188265-58-8
Package:10Mg,1Mg
Company Name: Cato Research Chemicals Inc.  
Tel: 020-81960175
Email: min.he@cato-chem.com
Products Intro: Product Name:ZonisaMide-13C2-15N
CAS:1188265-58-8
Purity:95% Package:25Mg, 50Mg
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Products Intro: Product Name:Zonisamide-13C2-15N
CAS:1188265-58-8
Purity:95% Package:1mg
Company Name: Shanghai QianYan Bio-technology Co., Ltd  
Tel: 02781293128
Email: orders@biochemsafebuy.com
Products Intro: Product Name:Zonisamide-13C2-15N
CAS:1188265-58-8
Purity:>98% .NMR+LCMS Package:50Mg/100Mg/500Mg/1g/5g/10g/

ZONISAMIDE-13C2-15N manufacturers

  • Zonisamide-13C2,15N
  • Zonisamide-13C2,15N pictures
  • $990.00 / 1mg
  • 2025-08-21
  • CAS:1188265-58-8
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
ZONISAMIDE-13C2-15N Basic information
Product Name:ZONISAMIDE-13C2-15N
Synonyms:ZONISAMIDE-13C2-15N;13C2,15N]-Zonisamide
CAS:1188265-58-8
MF:C8H8N2O3S
MW:215.25
EINECS:
Product Categories:
Mol File:Mol File
ZONISAMIDE-13C2-15N Structure
ZONISAMIDE-13C2-15N Chemical Properties
Melting point 158 - 160°C
storage temp. Refrigerator
solubility DMSO (Sparingly), Methanol (Slightly)
form Solid
color Off-White to Light Yellow
Safety Information
MSDS Information
ZONISAMIDE-13C2-15N Usage And Synthesis
DescriptionZonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide is an antiepileptic agent. It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml. In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium current. Zonisamide inhibits H. pylori recombinant carbonic anhydrase (CA) and the human CA isoforms I, II, and V with Ki values of 218, 56, 35, and 21 nM, respectively. In mice, it has anticonvulsant activity against maximal electroshock seizure (MES) and pentylenetetrazole-induced maximal, but not minimal, seizures (ED50s = 19.6, 9.3, and >500 mg/kg, respectively). Zonisamide (40 mg/kg, p.o.) prevents MPTP-induced decreases in the levels of dopamine , but not homovanillic acid (HVA; ) or dihydroxyphenyl acetic acid (DOPAC; ), and increases MPTP-induced decreases in the dopamine turnover rate in mouse striatum in a model of Parkinson''s disease. Formulations containing zonisamide have been used in the treatment of partial seizures in adults with epilepsy.
UsesZonisamide-13C2-15N is the labeled analogue of Zonisamide (Z700000), a sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation for potential therapeutic use as an antiepileptic drug. Anticonvulsant.
References[1] YOSHINOBU MASUDA  Masanao S  Masayuki Ishizaki. Zonisamide: Pharmacology and Clinical Efficacy in Epilepsy[J]. CNS drug reviews, 2006, 4 4: 341-360. DOI: 10.1111/j.1527-3458.1998.tb00075.x
[2] DAVID M ROCK  Charles P T  Robert L Macdonald. Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant[J]. Epilepsy Research, 1989, 3 2: Pages 138-143. DOI: 10.1016/0920-1211(89)90041-7
[3] SETSUO SUZUKI. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex[J]. Epilepsy Research, 1992, 12 1: Pages 21-27. DOI: 10.1016/0920-1211(92)90087-a
[4] ISAO NISHIMORI . Carbonic anhydrase inhibitors: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori[J]. Bioorganic & Medicinal Chemistry Letters, 2006, 16 8: Pages 2182-2188. DOI: 10.1016/j.bmcl.2006.01.044
[5] GIUSEPPINA DE SIMONE . Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies[J]. Bioorganic & Medicinal Chemistry Letters, 2005, 15 9: Pages 2315-2320. DOI: 10.1016/j.bmcl.2005.03.032
[6] HAYATO YABE . Zonisamide Increases Dopamine Turnover in the Striatum of Mice and Common Marmosets Treated With MPTP[J]. Journal of pharmacological sciences, 2009, 110 1: Pages 64-68. DOI: 10.1254/jphs.09019fp
ZONISAMIDE-13C2-15N Preparation Products And Raw materials
Tag:ZONISAMIDE-13C2-15N(1188265-58-8) Related Product Information
Zonisamide-d4 Zonisamide sodium salt Zonisamide-N-(6-hexanoic Acid) Zonisamide

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.